Cypress Development announced positive results from a prefeasibility study of the company’s Clayton Valley lithium project in Nevada, US.
Flower One is postponing the filing of its 2019 fourth quarter and year-end financial results and accompanying management's discussion and...
Humanigen announced that the first COVID-19 patient has been dosed in its previously announced Phase III study.
The New Rochelle Police Department has entered into a subscription agreement for the company's Watchman vehicle recognition software.
Health Canada has approved AbbVie's VENCLEXTA in combination with obinutuzumab to treat adult patients with previously untreated CLL.
Inomin Mines announced that it has entered into an agreement to acquire private Australian company Canada Metals.
Gilead Sciences announced the results of a Phase 3 trial of investigational antiviral remdesivir in patients with severe COVID-19.